|
1
|
Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium.
|
Heart Rhythm
|
2010
|
1.89
|
|
2
|
Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm.
|
Europace
|
2009
|
1.42
|
|
3
|
Effects of iron oxide nanoparticles on cardiac differentiation of embryonic stem cells.
|
Biochem Biophys Res Commun
|
2009
|
1.02
|
|
4
|
Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells.
|
Aging (Albany NY)
|
2012
|
1.00
|
|
5
|
A review of the anticancer and immunomodulatory effects of Lycium barbarum fruit.
|
Inflammopharmacology
|
2011
|
1.00
|
|
6
|
Electrical stimulation promotes maturation of cardiomyocytes derived from human embryonic stem cells.
|
J Cardiovasc Transl Res
|
2013
|
0.96
|
|
7
|
Exogenous expression of HIF-1 alpha promotes cardiac differentiation of embryonic stem cells.
|
J Mol Cell Cardiol
|
2010
|
0.95
|
|
8
|
Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing.
|
Hum Mol Genet
|
2013
|
0.95
|
|
9
|
ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system.
|
Cell Reprogram
|
2010
|
0.92
|
|
10
|
Exogenous expression of human apoA-I enhances cardiac differentiation of pluripotent stem cells.
|
PLoS One
|
2011
|
0.92
|
|
11
|
Therapeutic application of endothelial progenitor cells for treatment of cardiovascular diseases.
|
Curr Stem Cell Res Ther
|
2014
|
0.84
|
|
12
|
Cobalt chloride pretreatment promotes cardiac differentiation of human embryonic stem cells under atmospheric oxygen level.
|
Cell Reprogram
|
2011
|
0.79
|
|
13
|
Modeling of human cardiomyopathy with induced pluripotent stem cells.
|
J Biomed Nanotechnol
|
2014
|
0.75
|